A highly notable options trade was spotted in UnitedHealth (UNH), featuring a sweep of 2,044 contracts for the April 24, 2026 $280 call. The contract has just about 32 days to expiration. What stands out immediately is the extremely elevated volume-to-open interest ratio (V/OI) of roughly 113.6x (2,044 volume vs. just 18 open interest). This indicates that almost all of today’s volume was entirely new positioning rather than existing contracts being traded.
The contracts were bought above the ask, reinforcing strong buyer urgency and conviction. With a total premium outlay of approximately $2.6 million and a spot price of $274.83, the trade is slightly out-of-the-money. This suggests expectations for near-term movement. Overall, this sweep reflects aggressive sentiment and signals that a large player is positioning for a potential breakout around the $280 level in the coming weeks.
Volume and Open Interest Data
The volume and open interest profile for the UNH April 24, 2026 $280 call shows a dramatic surge in activity on 03/23/26. On that day, volume spiked to 2,133 contracts. Compared to just 18 open interest, this confirms a massive influx of new positions rather than closing trades. In the days prior, volume remained extremely low (single to low double digits) while OI stayed relatively flat. The differential highlights just how unusual this spike is.
Despite the heavy buying, open interest only increased modestly (+6) from the previous trading session. This suggests that many of these contracts were newly opened but may not have fully settled yet or were partially offset intraday. Additionally, the contract price has been trending downward from around $19 to $12.30 over the same period, even as volume exploded—potentially indicating buyers stepping in aggressively on weakness. Overall, this setup reflects a sudden and significant bet being placed, with traders expecting volatility in UNH despite recent premium compression.
What’s Happening with UNH
UnitedHealth Group is emerging from a very difficult 2025 marked by a major Change Healthcare cyberattack, elevated Medicare Advantage medical costs, leadership upheaval, and regulatory scrutiny, and is now emphasizing margin repair and a “back to basics” focus for 2026. The Change Healthcare breach in early 2024 created a claims backlog exceeding $14 billion and is expected to cost over $1 billion in direct and related expenses. This forces the company to advance billions in temporary payments to providers and deal with ongoing legal fallout.
Operationally, UnitedHealth is cutting benefits and accepting lower Medicare Advantage membership in 2026 to restore profitability.Analysts expect MA margins to recover to roughly 2–3% as the company prioritizes pricing discipline over growth.
Financially, UnitedHealth reported 2025 revenue of about $447.6 billion, up 12% year over year, but with pressured earnings, and it now guides 2026 EPS to above roughly the high‑$17 range while the stock remains well below prior highs. Governance-wise, long‑time former CEO Stephen Hemsley has returned to the top job after Andrew Witty’s resignation, signaling a move to stabilize strategy as the group manages higher utilization trends and political pressure around Medicare Advantage and ACA premiums.
About UNH
UnitedHealth Group is a diversified healthcare and insurance company headquartered in the United States, operating primarily through two key segments: UnitedHealthcare and Optum. UnitedHealthcare provides a broad range of health insurance plans and services to individuals, employers, and government programs like Medicare and Medicaid.
Optum, its health services arm, focuses on data-driven care delivery, pharmacy benefits management, and health technology solutions. Together, the company combines clinical expertise, data analytics, and a vast provider network to deliver integrated health solutions aimed at improving outcomes while managing costs across the healthcare ecosystem.
Analyst Ratings
| Firm | Rating | Datum |
|---|---|---|
| CFRA | ★★★ (3/5) | 03/21/2026 |
| Market Edge | Avoid | 02/13/2026 |
| Argus | Hold | 01/29/2026 |
| Morningstar | ★★★★ (4/5) | 03/11/2026 |
| LSEG | Outperform | 03/20/2026 |
| Schwab Equity Ratings | B | 03/22/2026 |
Analyst sentiment on UnitedHealth (UNH) appears mixed but slightly skewed bullish. While Market Edge maintains a cautious “Avoid” stance, most other firms lean neutral-to-positive. Argus rates the stock a Hold, and CFRA sits in the middle with a 3-star rating, indicating balanced expectations.
On the bullish side, Morningstar assigns 4 stars, LSEG rates UNH as Outperform, and Schwab gives it a solid “B” grade, reflecting confidence in above-average performance. Overall, despite some lingering caution, the majority of analysts suggest moderate upside potential, with improving sentiment in more recent updates.
Want to see more of these trades? Try out Cheddar Flow free for 7 days. Learn More
Disclaimer: Options trading involves significant risk and is not suitable for all investors. You may lose the entire investment, and certain strategies may result in losses exceeding the initial amount invested. Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice. Always consult a financial or tax advisor before making investment decisions.
